http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03066626-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7517be8f45afd10be473163f042a0fa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_140efd2b9eb2b06e03a74087d604085b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56356cebacdaf7ac1d5050a40686aa1d |
publicationDate | 2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-03066626-A1 |
titleOfInvention | Deuterated biphenyl-substituted benzimidazoles and medicament containing said compounds for the treatment of hypertonia |
abstract | The invention relates to deuterated biphenyl-substituted benzimidazoles and to medicaments containing said compounds. The invention further relates to the use of said deuterated biphenyl-substituted benzimidazoles for vasodilatation, especially for the treatment of hypertonia, and to the production of corresponding medicaments. The invention also relates to pharmaceutical compounds containing deuterated biphenyl-substituted benzimidazoles and the physiologically acceptable salts thereof, in addition to pharmaceutically acceptable adjuvants and/or additives for vasodilatation, especially for the treatment of hypertonia. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008067378-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008067378-A2 |
priorityDate | 2002-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.